Preoperative Crohn's Disease Exclusion Diet and Exclusive Enteral Nutrition in Adults with Crohn's Disease: A Feasibility Randomised Controlled Trial.

Crohn’s disease Crohn’s disease exclusion diet exclusive enteral nutrition nutritional optimization oral nutrition supplements preoperative rehabilitation surgery surgical complications

Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
02 Jul 2024
Historique:
received: 23 05 2024
revised: 20 06 2024
accepted: 21 06 2024
medline: 13 7 2024
pubmed: 13 7 2024
entrez: 13 7 2024
Statut: epublish

Résumé

Preoperative exclusive enteral nutrition (EEN) improves nutritional status, reduces intestinal inflammation, and likely improves surgical outcomes. Crohn's disease exclusion diet with partial enteral nutrition (CDED) also reduces intestinal inflammation but its safety preoperatively is unknown. This single-blinded, multicentre, randomised controlled trial of three preoperative nutritional therapies aimed to assess the feasibility of recruiting and retaining patients and collecting primary and secondary effectiveness outcomes. Adults undergoing elective Crohn's disease surgery with a body mass index (BMI) > 18.5 kg/m

Identifiants

pubmed: 38999853
pii: nu16132105
doi: 10.3390/nu16132105
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : New Zealand Health Research Council
ID : Emerging Researcher First Grant

Auteurs

Catherine L Wall (CL)

Department of Medicine, University of Otago, Christchurch 8011, New Zealand.

Rachael Bensley (R)

Department of Medicine, University of Otago, Christchurch 8011, New Zealand.

Tamara Glyn (T)

Department of Surgery and Critical Care, University of Otago, Christchurch 8011, New Zealand.
Christchurch Hospital, Te Whatu Ora Health New Zealand Waitaha Canterbury, Christchurch 8011, New Zealand.

Melissa Haines (M)

Waikato Hospital, Te Whatu Ora Health New Zealand Waikato, Hamilton 3240, New Zealand.

David Rowbotham (D)

Auckland City Hospital, Te Whatu Ora Health New Zealand Te Toka Tumai, Auckland 1023, New Zealand.

Ian Bissett (I)

Auckland City Hospital, Te Whatu Ora Health New Zealand Te Toka Tumai, Auckland 1023, New Zealand.
Department of Surgery, The University of Auckland, Auckland 1023, New Zealand.

Timothy Eglinton (T)

Department of Surgery and Critical Care, University of Otago, Christchurch 8011, New Zealand.
Christchurch Hospital, Te Whatu Ora Health New Zealand Waitaha Canterbury, Christchurch 8011, New Zealand.

Richard B Gearry (RB)

Department of Medicine, University of Otago, Christchurch 8011, New Zealand.
Christchurch Hospital, Te Whatu Ora Health New Zealand Waitaha Canterbury, Christchurch 8011, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH